Deveraux QL - Search Results

1

Activation and suppression of the TRAIL death-receptor pathway in chemotherapy sensitive and resistant follicular lymphoma cells.

Wagner KW, King F, Nomoto K, Knee DA, Hampton G, Nasoff M, Deveraux QL. Wagner KW, et al. Among authors: deveraux ql. Cancer Biol Ther. 2003 Sep-Oct;2(5):534-40. doi: 10.4161/cbt.2.5.453. Cancer Biol Ther. 2003. PMID: 14614322 Free article.

2

Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway.

Wang Y, Engels IH, Knee DA, Nasoff M, Deveraux QL, Quon KC. Wang Y, et al. Among authors: deveraux ql. Cancer Cell. 2004 May;5(5):501-12. doi: 10.1016/s1535-6108(04)00113-8. Cancer Cell. 2004. PMID: 15144957 Free article.

3

Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway.

Wagner KW, Engels IH, Deveraux QL. Wagner KW, et al. Among authors: deveraux ql. J Biol Chem. 2004 Aug 13;279(33):35047-52. doi: 10.1074/jbc.M400708200. Epub 2004 Jun 1. J Biol Chem. 2004. PMID: 15173176 Free article.

4

Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle.

Ren YG, Wagner KW, Knee DA, Aza-Blanc P, Nasoff M, Deveraux QL. Ren YG, et al. Among authors: deveraux ql. Mol Biol Cell. 2004 Nov;15(11):5064-74. doi: 10.1091/mbc.e04-03-0184. Epub 2004 Sep 8. Mol Biol Cell. 2004. PMID: 15356269 Free PMC article.

5

A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function.

Rottmann S, Wang Y, Nasoff M, Deveraux QL, Quon KC. Rottmann S, et al. Among authors: deveraux ql. Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15195-200. doi: 10.1073/pnas.0505114102. Epub 2005 Oct 6. Proc Natl Acad Sci U S A. 2005. PMID: 16210249 Free PMC article.

6

Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening.

Aza-Blanc P, Cooper CL, Wagner K, Batalov S, Deveraux QL, Cooke MP. Aza-Blanc P, et al. Among authors: deveraux ql. Mol Cell. 2003 Sep;12(3):627-37. doi: 10.1016/s1097-2765(03)00348-4. Mol Cell. 2003. PMID: 14527409 Free article.

7

Exposing oncogenic dependencies for cancer drug target discovery and validation using RNAi.

Deveraux QL, Aza-Blanc P, Wagner KW, Bauerschlag D, Cooke MP, Hampton GM. Deveraux QL, et al. Semin Cancer Biol. 2003 Aug;13(4):293-300. doi: 10.1016/s1044-579x(03)00043-9. Semin Cancer Biol. 2003. PMID: 14563124 Review.

8

Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin.

Wagner KW, Sapinoso LM, El-Rifai W, Frierson HF, Butz N, Mestan J, Hofmann F, Deveraux QL, Hampton GM. Wagner KW, et al. Among authors: deveraux ql. Oncogene. 2004 Aug 26;23(39):6621-9. doi: 10.1038/sj.onc.1207861. Oncogene. 2004. PMID: 15208666

9

Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction.

Wu TY, Wagner KW, Bursulaya B, Schultz PG, Deveraux QL. Wu TY, et al. Among authors: deveraux ql. Chem Biol. 2003 Aug;10(8):759-67. doi: 10.1016/s1074-5521(03)00157-1. Chem Biol. 2003. PMID: 12954335

10

Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma.

Rue SM, Eckelman BP, Efe JA, Bloink K, Deveraux QL, Lowery D, Nasoff M. Rue SM, et al. Among authors: deveraux ql. Vet Immunol Immunopathol. 2015 Apr 15;164(3-4):148-59. doi: 10.1016/j.vetimm.2015.02.004. Epub 2015 Feb 18. Vet Immunol Immunopathol. 2015. PMID: 25764941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters